Trial
NCT04469062
A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Ulcerative Colitis
Intervention
Mirikizumab IV
Why stopped
The trial was terminated secondary to a business decision, the original scientific question rendered moot by the external scientific community.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-06